Vestor Capital’s Edwards Lifesciences EW Stock Holding History

Vestor Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$137K	Sell	1,694 -2,632	-61%	-$234K	0.01%	167
2026 Q2	$1.15M	Buy	4,326 +1,386	+47%	+$116K	0.07%	98
2026 Q1	$235K	Buy	2,940 +1,046	+55%	+$86.2K	0.02%	148
2025 Q4	$251K	Sell	1,894 -1,046	-36%	-$85.8K	0.02%	132
2025 Q3	$229K	Sell	2,940 -65,832	-96%	-$5.14M	0.01%	152
2025 Q2	$2.18M	Buy	68,772 +65,832	+2,239%	+$4.91M	0.16%	78
2025 Q1	$213K	Sell	2,940 -72	-2%	-$5.15K	0.02%	133
2024 Q4	$223K	Buy	3,012 +18	+0.6%	+$1.26K	0.02%	151
2024 Q3	$198K	Buy	2,994 +54	+2%	+$3.92K	0.02%	129
2024 Q2	$272K	Hold	2,940	–	–	0.02%	107
2024 Q1	$281K	Hold	2,940	–	–	0.02%	119
2023 Q4	$224K	Buy	+2,940	New	+$205K	0.02%	119

Other funds holding EW

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Vestor Capital's EW Position: Q3 2026 in Review

Vestor Capital reduced its Edwards Lifesciences (EW) stake by 61% in Q3 2026, selling an estimated $234K and leaving 1,694 shares worth $137K. The position accounts for 0.01% of the portfolio, ranked #167.

Vestor Capital first reported a position in EW in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.18M in Q2 2025. 980 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Vestor Capital held 1,694 shares of Edwards Lifesciences worth $137K as of Q3 2026.
Vestor Capital sold 2,632 Edwards Lifesciences shares in Q3 2026, an estimated $234K.
Edwards Lifesciences made up 0.01% of Vestor Capital's portfolio in Q3 2026, its #167 holding.
Vestor Capital first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
Vestor Capital's Edwards Lifesciences position peaked at $2.18M in Q2 2025.
980 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Vestor Capital's 13F filing for Q3 2026, filed 3 Nov 2026.